10 news items
Bristol Myers Updates Action Date for Subcutaneous Opdivo
ALXO
BMY
LGND
23 May 24
combination therapy, or in combination with chemotherapy or cabozantinib.
The BLA was accepted earlier this month with a target action date
HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target
LGND
8 May 24
HC Wainwright & Co. analyst Joseph Pantginis reiterates Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and maintains $144 price target.
Ligand Reports First Quarter 2024 Financial Results
AMGN
CASI
JAZZ
7 May 24
accelerated approval to full approval for the treatment of IgAN in the U.S. with a PDUFA target action date of September 5, 2024
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
AGEN
LGND
7 May 24
in multiple oncology products diversified across targets and indications, including royalties on BOT/BAL and several partnered oncology programs being
Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target
LGND
12 Apr 24
Benchmark analyst Robert Wasserman reiterates Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and maintains $95 price target.
32g05fp9o8wcy8qenyywgheap1s5cb
LGND
8 Apr 24
to rapidly attain targeted plasma drug concentrations in patients when there is a delay in initiating replacement therapy, in patients who are getting
bpaqs8cir 4jtt3qkbwvvm34c9qroxfn8b05i
LGND
29 Feb 24
HC Wainwright & Co. analyst Joseph Pantginis reiterates Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and maintains $144 price target.
gr3xaa321 mugcs4af2lz7t
AAN
AHCO
ALPP
27 Feb 24
. (NYSE:BBAI) rose 26% to $3.14. Cantor Fitzgerald analyst Yi Fu Lee maintained BigBear.ai with an Overweight and maintained $3 price target
nv8rj
AHCO
BBAI
BEAM
27 Feb 24
target.
Ligand Pharmaceuticals Incorporated
eifpvk6zg9e opb9ia8jj8s1p0gmtulaunnqjzbxr1ypbot59hs6oll
ALDX
LGND
MRK
27 Feb 24
condition. The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 17, 2024. If approved, Ligand is entitled to a low single
- Prev
- 1
- Next